QSAR - Predictive Toxicology Conference -- Dec. 2-3 in Philadelphia

Presenting:

Barnett International's
Predictive Toxicology
Strategies to Reduce Late Stage Drug Failures and Address Bottlenecks of
In-vitro and In-vivo Toximetabolism Using High-Throughput Methods
December 2-3, 2004 * Loews Hotel * Philadelphia, PA
<http://www.barnettinternational.com/RSC_PDFUploads//BI4011WEB.pdf>

$70 million of the total R&D costs per drug are spent on ADME/Tox failures!
Due to the high cost of late-stage failure and the impact of adverse drug
reactions, it is critical to eliminate toxic compounds as early as possible
in the drug development process. This comprehensive event featuring
industry, academic and agency case studies offers strategies to reduce late
stage drug failures and address bottlenecks of in-vitro and in-vivo
toximetabolism.

When registering as a member of the QSAR and Modeling Society please request
your 15% discount!

Phone: (610) 565-2622, ext. 2200
Email: customer.service(_)parexel.com

Please feel free to email Micah Lieberman directly with any questions:
micah.lieberman**parexel.com
Received on 2004-10-17 - 02:21 GMT